XDND:XETRA:XETRA-Xtrackers MSCI North America High Dividend Yield UCITS ETF 1C (EUR)

ETF | Others |

Last Closing

USD 53.41

Change

0.00 (0.00)%

Market Cap

USD 0.14B

Volume

3.80K

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-01-05 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
XM1D:XETRA Xtrackers MSCI Japan UCITS ETF..

-0.05 (-0.10%)

USD 446.30B
LCUJ:XETRA Lyxor Core MSCI Japan (DR) UCI..

-0.01 (-0.07%)

USD 191.96B
PRAJ:XETRA Amundi Index Solutions - Amund..

-0.09 (-0.32%)

USD 177.46B
PR1J:XETRA Amundi Prime Japan UCITS ETF D..

+0.07 (+0.23%)

USD 177.46B
XDJP:XETRA Xtrackers Nikkei 225 UCITS ETF..

-0.08 (-0.32%)

USD 157.79B
JARI:XETRA Amundi Index Solutions - Amund..

-0.29 (-0.62%)

USD 104.21B
8R80:XETRA Amundi Index Solutions - Amund..

+0.82 (+0.58%)

USD 102.09B
UIM5:XETRA UBS (Lux) Fund Solutions - MSC..

-0.03 (-0.06%)

USD 85.64B
EUNL:XETRA iShares Core MSCI World UCITS ..

+0.59 (+0.56%)

USD 84.07B
SXR8:XETRA iShares Core S&P 500 UCITS ETF..

+3.26 (+0.53%)

USD 80.38B

ETFs Containing XDND:XETRA

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 1.71% 78% C+ 75% C
Dividend Return N/A N/A N/A N/A N/A
Total Return 1.71% 78% C+ 75% C
Trailing 12 Months  
Capital Gain 18.44% 68% D+ 69% C-
Dividend Return N/A N/A N/A N/A N/A
Total Return 18.44% 67% D+ 68% D+
Trailing 5 Years  
Capital Gain 51.03% 75% C 75% C
Dividend Return N/A N/A N/A N/A N/A
Total Return 51.03% 73% C 72% C
Average Annual (5 Year Horizon)  
Capital Gain 12.16% 73% C 71% C-
Dividend Return 12.16% 72% C 70% C-
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 11.53% 56% F 64% D
Risk Adjusted Return 105.41% 93% A 93% A
Market Capitalization 0.14B 39% F 35% F

Annual Financials (EUR)

Quarterly Financials (EUR)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

What to not like:
Low market capitalization

This is among the smaller entities in its sectors with below median market capitalization. That may make it less stable in the long run unless it has a unique technology or market which can help it grow or get acquired in future.